LD02GIFRO
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LD02GIFRO, covering 2013-02-27 to 2013-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Effect on Recovery of GI Motility and Safety and to Determine the Optimal Dose of LD02GIFRO [Phase 2]